- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jaguar Health Inc (JAGX)
Jaguar Health Inc stock price live, this page displays NASDAQ JAGX stock exchange data. View the JAGX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jaguar Health Inc real time stock price chart below.
What Is the Jaguar Health Inc Stock Price Today?
The Jaguar Health Inc stock price today is 2.1400.
What Is the Stock Symbol for Jaguar Health Inc?
The stock symbol for Jaguar Health Inc is ""JAGX.""
What Stock Exchange Does Jaguar Health Inc Trade On?
Jaguar Health Inc is listed and trades on the NASDAQ stock exchange.
Is Jaguar Health Inc a Good Stock to Buy?
Determining whether Jaguar Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JAGX quote. (ISIN: US47010C8881)
What Is the Jaguar Health Inc Stock Price Today?
The Jaguar Health Inc stock price today is 2.1400.
What Is the Stock Symbol for Jaguar Health Inc?
The stock symbol for Jaguar Health Inc is ""JAGX.""
What Stock Exchange Does Jaguar Health Inc Trade On?
Jaguar Health Inc is listed and trades on the NASDAQ stock exchange.
Is Jaguar Health Inc a Good Stock to Buy?
Determining whether Jaguar Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JAGX quote. (ISIN: US47010C8881)
NASDAQ
Currency in USD
2.1400
+0.0400(+1.90%)
Closed·
After Hours
2.2200+0.0800(+3.74%)
·
Fair Value
An estimate of a Jaguar Health's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.0200
2.1988
52 wk Range
1.9301
35.2500
JAGX Scorecard
Full Analysis
Operates with a significant debt burden
JAGX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Jaguar Health's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.02002.1988
52 wk Range
1.930135.2500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
JAGX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Jaguar Health's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
28.0000
Upside
+1,208.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Jaguar Health Inc For: 30 June
- Investing.com
- Form 8K Jaguar Health Inc For: 30 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Jaguar Health Inc Company Profile
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. The company operates through two segments, Animal Health and Human Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company offers Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase III clinical trial for prophylaxis of diarrhea in adult cancer patients; Phase II clinical trials for rare/orphan disease indications, including short bowel syndrome with intestinal failure and microvillus inclusion disease; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing Mytesi which is in Phase III clinical trial for cancer therapy-related diarrhea, as well as Phase II clinical trial for irritable bowel syndrome; and NP-300, a second-generation antidiarrheal drug that is in Phase I clinical trial for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California.
Jaguar Health Inc Earnings Call Summary for Q1/2025
- Q1 2025 revenue fell 6% YoY to $2.2M; stock dropped 10.86% to $6.17
- Loss from operations increased to $9.4M; net loss to shareholders at $10.4M
- Company advancing trials for rare diseases; CEO highlights 'groundbreaking' research
- Facing financial challenges with high debt and cash burn; market cap at $3.69M
- Focus on pipeline development and non-dilutive funding to support strategic goals
Last Updated: 15/05/2025, 22:08
Read Full TranscriptCompare JAGX to Peers and Sector
Metrics to compare | JAGX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJAGXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −0.1x | −0.5x | |
PEG Ratio | 0.00 | 0.06 | 0.00 | |
Price/Book | 2.3x | 0.7x | 2.6x | |
Price / LTM Sales | 0.4x | 1.4x | 3.3x | |
Upside (Analyst Target) | - | 96.1% | 43.5% | |
Fair Value Upside | Unlock | 20.0% | 6.8% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 28.0000
(+1,208.41% Upside)
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-16.70 / -0.34
Revenue / Forecast
2.21M / 4.69M
People Also Watch
FAQ
What Stock Exchange Does Jaguar Health Trade On?
Jaguar Health is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Jaguar Health?
The stock symbol for Jaguar Health is "JAGX."
What Is the Jaguar Health Market Cap?
As of today, Jaguar Health market cap is 4.10M.
What Is Jaguar Health's Earnings Per Share (TTM)?
The Jaguar Health EPS (TTM) is -93.54.
From a Technical Analysis Perspective, Is JAGX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Jaguar Health Stock Split?
Jaguar Health has split 6 times.
How Many Employees Does Jaguar Health Have?
Jaguar Health has 49 employees.
What is the current trading status of Jaguar Health (JAGX)?
As of 09 Aug 2025, Jaguar Health (JAGX) is trading at a price of 2.14, with a previous close of 2.10. The stock has fluctuated within a day range of 2.02 to 2.20, while its 52-week range spans from 1.93 to 35.25.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.